References
- Nasso G, Piancone F, Bonifazi R, et al. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg 2009;88:1520-6
- Tackett S, Calcaterra D, Magee G, et al. Real world outcomes of hemostatic matrices in cardiac surgery. J Cardiothorac Vasc Anesth 2014;28:1558-65
- Price J, Tackett S, Patel V. Observational evaluation of outcomes and resource utilization from hemostatic matrices in spine surgery. J Med Econ 2015;18:777-86
- Moulton MJ, Creswell LL, Mackey ME, et al. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg 1996;111:1037-46
- Dacey LJ, Munoz JJ, Baribeau YR, et al. Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Arch Surg 1998;133:442-7
- Unsworth-White MJ, Herriot A, Valencia O, et al. Resternotomy for bleeding after cardiac operation: a marker for increased morbidity and mortality. Ann Thorac Surg 1995;59:664-7
- Stokes ME, Ye X, Shah M, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res 2011;11:1-13
- Renkens KL, Payner TD, Leipzig TJ, et al. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spine surgery. Spine 2001;26:1645-50
- Oz MC, Cosgrove DM, Badduke BR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. Ann Thorac Surg 2000;69:1376-82
- FLOSEAL VH S/D Instructions for Use. Deerfield, IL: Baxter Healthcare Corporation; 2005
- SURGIFLO Instructions for Use. Somerville, NJ: J & J Wound Management; 2008
- Mozet C, Prettin C, Dietze M, et al. Use of Floseal and effects on wound healing and pain in adults undergoing tonsillectomy: Randomised comparison versus electrocautery. Eur Arch Otorhinolaryngol 2012;269:2247-54
- Chapman WC, Singla N, Genyk Y, et al. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. J Am Coll Surg 2007;205:256-65
- Lewis K, Atlee H, Mannone A, et al. Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model. J Invest Surg 2013;26:141-8
- Coenye KE, Bourgain C, Keibl C, et al. A qualitative morphological comparison of two haemostatic agents in a porcine liver trauma model. Surg Sci 2013;4:359-64
- David G, Lim S, Gunnarsson C, et al. Similar patient outcomes yet different hospital costs between flowable hemostatic agents. J Med Econ 2015;18:735-45
- Premier Inc. Premier PerspectiveTM Hospital Database. Charlotte, NC: Premier Inc.; 2012
- 2012 Healthcare Cost and Utilization Project’s (HCUP’s) National Inpatient Sample (NIS) Database. https://www.hcup-us.ahrq.gov/databases.jsp. Accessed February 10, 2016
- Chatterjee A, Payette MJ, Demas CP, et al. Opportunity cost: a systematic application to surgery. Surgery 2009;146:18-22
- Tackett S, Sugarman R, Kreuwel H, et al. Hospital economic impact from hemostatic matrix usage in cardiac surgery. J Med Econ 2014;17:670-6